NCT05406726View on ClinicalTrials.gov

Mechanisms of Palmitoylethanolamide (PEA) to Alter Pain Sensitivity in Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

January 2, 2024

Study Completion Date

January 2, 2024

Conditions
Osteoarthritis, Knee
Interventions
DIETARY_SUPPLEMENT

palmitoylethanolamide

palmitoylethanolamide is an lipid based endocannabinoid naturally made by the body and is present in several common foods such as eggs

DIETARY_SUPPLEMENT

Placebo

a capsule filled only with maltodextrin will be used as a placebo

Trial Locations (1)

21201

University of Maryland, Baltimore, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER